Nimh psychoactive drug screening program (pdsp)

The National Institute of Mental Health seeks proposals to provide screening services for the Psychoactive Drug Screening Program through solicitation number NIH-NIMH-75N95023R00003. Services include pharmacological and functional screening of approximately 2,500-3,000 psychoactive drug samples per year across over 100 binding and functional assays. A single cost reimbursement contract will be awarded for an initial one-year base period and four one-year option periods, with proposals due by March 1, 2023. Proposals will be evaluated based on offerors' technical approach, management plan, staff qualifications, and price.

The solicitation uses NAICS code 541715 for research and development in the physical, engineering, and life sciences with no set-aside designated. The single award is anticipated to range from $5-10M annually to screen 2,500-3,000 samples across 125,000 functional assays and 45,000 binding assays. Performance will take place within the United States at the offeror's proposed location. The National Institute on Drug Abuse within the Department of Health and Human Services is the contracting agency.